Assuntos
Anestésicos Locais , Bupivacaína , Humanos , Dexametasona , Dor Pós-Operatória , LipossomosAssuntos
COVID-19 , Insuficiência Respiratória , Humanos , Vigília , Estudos de Viabilidade , SARS-CoV-2 , Respiração ArtificialAssuntos
COVID-19 , Síndrome do Desconforto Respiratório , Insuficiência Respiratória , Humanos , Hipercapnia , Insuficiência Respiratória/terapia , Insuficiência Respiratória/etiologia , Síndrome do Desconforto Respiratório/terapia , Síndrome do Desconforto Respiratório/etiologia , Respiração Artificial/efeitos adversosRESUMO
We thank Salama S et al [...].
Assuntos
Respiração com Pressão Positiva , Doença Pulmonar Obstrutiva Crônica , Humanos , Pulmão , Doença Pulmonar Obstrutiva Crônica/terapia , RespiraçãoRESUMO
Aim: This systematic review aimed to investigate the drugs used and their potential effect on noninvasive ventilation (NIV). Background: NIV is used increasingly in acute respiratory failure (ARF). Sedation and analgesia are potentially beneficial in NIV, but they can have a deleterious impact. Proper guidelines to specifically address this issue and the recommendations for or against it are scarce in the literature. In the most recent guidelines published in 2017 by the European Respiratory Society/American Thoracic Society (ERS/ATS) relating to NIV use in patients having ARF, the well-defined recommendation on the selective use of sedation and analgesia is missing. Nevertheless, some national guidelines suggested using sedation for agitation. Methods: Electronic databases (PubMed/Medline, Google Scholar, and Cochrane library) from January 1999 to December 2019 were searched systematically for research articles related to sedation and analgosedation in NIV. A brief review of the existing literature related to sedation and analgesia was also done. Review results: Sixteen articles (five randomized trials) were analyzed. Other trials, guidelines, and reviews published over the last two decades were also discussed. The present review analysis suggests dexmedetomidine as the emerging sedative agent of choice based on the most recent trials because of better efficacy with an improved and predictable cardiorespiratory profile. Conclusion: Current evidence suggests that sedation has a potentially beneficial role in patients at risk of NIV failure due to interface intolerance, anxiety, and pain. However, more randomized controlled trials are needed to comment on this issue and formulate strong evidence-based recommendations. How to cite this article: Karim HMR, Sarc I, Calandra C, Spadaro S, Mina B, Ciobanu LD, et al. Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations. Indian J Crit Care Med 2022;26(8):938-948.
RESUMO
The impact of diuretics on the foetus is controversial, and thus they are not preferred during pregnancy [1]. Excessive fluid retention during late pregnancy can lead to acute pulmonary oedema (APO), which increases the foeto-maternal morbidity and mortality [2, 3]. Reported incidence is about 0.08%, which can become 1.5% in pre-eclampsia [2-4]. Although most commonly reported during late pregnancy and early puerperium, the occurrence of APO during labour is very rare [2, 3].